Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.04 (+4.36%)
At close: Aug 20, 2026 · 3:02 PM UTC

Akebia Therapeutics (AKBA) Sales of Property, Plant and Equipment (2025)

Akebia Therapeutics (AKBA) Sales of Property, Plant and Equipment (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 1.00 Mn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 6.88 Mn
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 8.20 Mn
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Akebia Therapeutics 247.98 Mn 92.43 Mn 38.70 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 172,000.00
Mar 31, 2025 172,000.00